In contrast, BCG plus indomethacin-treated BlCa tumors attracted significantly lower numbers of regulatory T(reg) cells (identified as CD4 +/FoxP3+ T cells) than the BCG-only-treated tumors, showing no increases in Treg attraction compared to the untreated tumors. The gene discussed is CD4; the disease is bladder transitional cell carcinoma.